These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12363392)

  • 1. Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia.
    Shirayama Y; Hashimoto K; Suzuki Y; Higuchi T
    Schizophr Res; 2002 Nov; 58(1):69-74. PubMed ID: 12363392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative correlation between negative symptoms of schizophrenia and testosterone levels.
    Goyal RO; Sagar R; Ammini AC; Khurana ML; Alias AG
    Ann N Y Acad Sci; 2004 Dec; 1032():291-4. PubMed ID: 15677432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.
    Strous RD; Maayan R; Lapidus R; Stryjer R; Lustig M; Kotler M; Weizman A
    Arch Gen Psychiatry; 2003 Feb; 60(2):133-41. PubMed ID: 12578430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum DHEA-S, Testosterone and Cortisol Levels in Female Patients with Schizophrenia.
    Bulut SD; Bulut S; Gundogmus AG; Aydemir C
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):348-354. PubMed ID: 29437023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids.
    Huang YC; Hung CF; Lin PY; Lee Y; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Wang LJ
    Psychoneuroendocrinology; 2017 Oct; 84():87-93. PubMed ID: 28686904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between sex hormone profiles and symptoms of schizophrenia in men.
    Doğan Bulut S; Bulut S; Güriz O
    Compr Psychiatry; 2016 Aug; 69():186-92. PubMed ID: 27423360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS; Strous RD
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives.
    Yıldırım O; Dogan O; Semiz M; Kilicli F
    Psychiatry Clin Neurosci; 2011 Oct; 65(6):584-91. PubMed ID: 21895860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal variations in androgens and stress hormones in control and schizophrenic subjects.
    Tourney G; Erb JL
    Biol Psychiatry; 1979 Apr; 14(2):395-404. PubMed ID: 157785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.
    Gallagher P; Watson S; Smith MS; Young AH; Ferrier IN
    Schizophr Res; 2007 Feb; 90(1-3):258-65. PubMed ID: 17222537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.
    Cai H; Zhou X; Dougherty GG; Reddy RD; Haas GL; Montrose DM; Keshavan M; Yao JK
    Psychoneuroendocrinology; 2018 Apr; 90():43-51. PubMed ID: 29433072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin and low-dose ACTH test in rheumatoid arthritis.
    Foppiani L; Cutolo M; Sessarego P; Sulli A; Prete C; Seriolo B; Giusti M
    Eur J Endocrinol; 1998 Mar; 138(3):294-301. PubMed ID: 9539304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.
    Strous RD; Maayan R; Lapidus R; Goredetsky L; Zeldich E; Kotler M; Weizman A
    Schizophr Res; 2004 Dec; 71(2-3):427-34. PubMed ID: 15474914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
    Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.